- Home
- ABEO vs PAYS Comparison
ABEO vs PAYS Comparison
Compare ABEO & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | PAYS |
|---|---|---|
| Founded | 1974 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.0M | 293.4M |
| IPO Year | 1980 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ABEO | PAYS |
|---|---|---|
| Price | $5.18 | $4.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $18.20 | $8.06 |
| AVG Volume (30 Days) | ★ 1.2M | 285.8K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.29 | 0.13 |
| Revenue | $400,000.00 | ★ $74,879,428.00 |
| Revenue This Year | N/A | $41.20 |
| Revenue Next Year | $1,589.77 | $20.62 |
| P/E Ratio | ★ $4.01 | $37.18 |
| Revenue Growth | N/A | ★ 32.61 |
| 52 Week Low | $3.93 | $1.80 |
| 52 Week High | $7.54 | $8.88 |
Technical Indicators
Market Signals| Indicator | ABEO | PAYS |
|---|---|---|
| Relative Strength Index (RSI) | 50.82 | 36.53 |
| Support Level | $5.11 | $4.92 |
| Resistance Level | $5.40 | $5.23 |
| Average True Range (ATR) | 0.22 | 0.20 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 49.33 | 3.25 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.